These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 117761)

  • 1. Analysis of a bivalent meningococcal vaccine (A + C). Part II. Stability.
    Arickx M; Crooy P; De Neys R; Gilles R; Liveyns R
    Ann Soc Belg Med Trop; 1979 Sep; 59(3):267-77. PubMed ID: 117761
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of a bivalent meningococcal vaccine (A + C). Part I. Analytical and safety data.
    Anhoury ML; Arickx M; Boon B; Crooy P; de Neys R; Dewez M; Gilles D; Goossens J; Liveyns R; Roelants P
    Ann Soc Belg Med Trop; 1979 Sep; 59(3):259-66. PubMed ID: 117760
    [No Abstract]   [Full Text] [Related]  

  • 3. A sensitive method for the determination of the molecular size of meningococcal polysaccharide vaccine.
    Helting TB; Kumpe M
    J Biol Stand; 1978; 6(2):111-5. PubMed ID: 418071
    [No Abstract]   [Full Text] [Related]  

  • 4. Standardization and control of meningococcal vaccines, group A and group C polysaccharides.
    Wong KH; Barrera O; Sutton A; May J; Hochstein DH; Robbins JD; Robbins JB; Parkman PD; Seligmann EB
    J Biol Stand; 1977; 5(3):197-215. PubMed ID: 408354
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunogenicity and side-effects of a new tetravalent meningococcal polysaccharide vaccine.
    Ambrosch F; Wiedermann G; Crooy P; George AM
    Bull World Health Organ; 1983; 61(2):317-23. PubMed ID: 6407768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and serological evaluation of a meningococcal polysaccharide vaccine groups A, C, Y, and W135.
    Hankins WA; Gwaltney JM; Hendley JO; Farquhar JD; Samuelson JS
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):54-7. PubMed ID: 6801667
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of polysaccharide vaccines for the prevention of meningococcal diseases.
    Gotschlich EC
    Monogr Allergy; 1975; 9():245-58. PubMed ID: 804088
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhanced stability of meningococcal polysaccharide vaccines by using lactose as a menstruum for lyophilization.
    Tiesjema RH; Beuvery EC; te Pas BJ
    Bull World Health Organ; 1977; 55(1):43-8. PubMed ID: 408022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the effectiveness of group-A and -C meningococcal polysaccharide vaccines by molecular parameters].
    Bobyleva GV; Kuvakina VI; Valerius II
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):758-63. PubMed ID: 3122649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.
    Wahdan MH; Rizk F; el-Akkad AM; el-Ghoroury AA; Hablas R; Girgis NI; Amer A; Boctar W; Sippel JE; Gotschlich EC; Triau R; Sanborn WR; Cvjetanović B
    Bull World Health Organ; 1973 Jun; 48(6):667-73. PubMed ID: 4206451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and control of Neisseria meningitidis vaccines.
    Frasch CE
    Adv Biotechnol Processes; 1990; 13():123-45. PubMed ID: 2110462
    [No Abstract]   [Full Text] [Related]  

  • 12. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [About proteinic impurities checking in a meningococcal vaccine. Mannitol interference in the Lowry protein determination (author's transl)].
    Bienvenu P; Hajjar R; Fontanges R
    Ann Pharm Fr; 1978; 36(5-6):263-8. PubMed ID: 101124
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Observations on the immune responses of infants and young children to group A meningococcal polysaccharide vaccine].
    Zhao JW
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Feb; 4(1):12-4. PubMed ID: 6411345
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningococcal polysaccharide vaccines.
    Gold R
    Hosp Pharm; 1977 Apr; 12(4):201. PubMed ID: 10305440
    [No Abstract]   [Full Text] [Related]  

  • 18. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunological responses observed in field studies in Africa with group A meningococcal vaccines.
    Gotschlich EC; Rey M; Etienne J; Sanborn WR; Triau R; Cvjetanović B
    Prog Immunobiol Stand; 1971; 5():485-91. PubMed ID: 4633975
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.